Cargando…
The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation
INTRODUCTION: The efficacy of pulmonary vein isolation (PVI) in atrial fibrillation (AF) is well documented. Several single nucleotide polymorphisms (SNPs) are associated with AF, mainly in the 4q25 locus, but also in 16q22 and 1q21. The aim of our study was to test the association between those SNP...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754358/ https://www.ncbi.nlm.nih.gov/pubmed/26925117 http://dx.doi.org/10.5114/aoms.2015.48284 |
_version_ | 1782416000165085184 |
---|---|
author | Kiliszek, Marek Kozluk, Edward Franaszczyk, Maria Lodzinski, Piotr Piatkowska, Agnieszka Ploski, Rafal Opolski, Grzegorz |
author_facet | Kiliszek, Marek Kozluk, Edward Franaszczyk, Maria Lodzinski, Piotr Piatkowska, Agnieszka Ploski, Rafal Opolski, Grzegorz |
author_sort | Kiliszek, Marek |
collection | PubMed |
description | INTRODUCTION: The efficacy of pulmonary vein isolation (PVI) in atrial fibrillation (AF) is well documented. Several single nucleotide polymorphisms (SNPs) are associated with AF, mainly in the 4q25 locus, but also in 16q22 and 1q21. The aim of our study was to test the association between those SNPs and short- and long-term results of PVI. MATERIAL AND METHODS: Patients with AF who underwent PVI between 2006 and 2009 were included in the study. Pulmonary vein isolation was performed using a 4-mm non-irrigated ablation catheter, circular mapping catheter, and the LocaLisa system. All patients were genotyped for the 4q25, 16q22, and 1q21 SNPs. RESULTS: Two-hundred and thirty-eight patients were included. The median follow-up was 45 months. Six-month efficacy was 59.7%. None of the polymorphisms was linked with the risk of AF recurrence after 6 months in univariate analysis. In multivariate analysis rs2200733 in the recessive model was linked significantly with AF recurrence (odds ratio 1.87, p = 0.008). None of the polymorphisms predicted AF recurrence in long-term follow-up. CONCLUSIONS: There is a trend in the relationship between TT genotype of the rs2200733 polymorphism and increased rate of AF recurrence after PVI in short-term (6 months) follow-up. None of the tested SNPs 4q25, 16q22, and 1q21 correlated with the results of a single AF ablation in long-term follow-up. |
format | Online Article Text |
id | pubmed-4754358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-47543582016-02-26 The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation Kiliszek, Marek Kozluk, Edward Franaszczyk, Maria Lodzinski, Piotr Piatkowska, Agnieszka Ploski, Rafal Opolski, Grzegorz Arch Med Sci Clinical Research INTRODUCTION: The efficacy of pulmonary vein isolation (PVI) in atrial fibrillation (AF) is well documented. Several single nucleotide polymorphisms (SNPs) are associated with AF, mainly in the 4q25 locus, but also in 16q22 and 1q21. The aim of our study was to test the association between those SNPs and short- and long-term results of PVI. MATERIAL AND METHODS: Patients with AF who underwent PVI between 2006 and 2009 were included in the study. Pulmonary vein isolation was performed using a 4-mm non-irrigated ablation catheter, circular mapping catheter, and the LocaLisa system. All patients were genotyped for the 4q25, 16q22, and 1q21 SNPs. RESULTS: Two-hundred and thirty-eight patients were included. The median follow-up was 45 months. Six-month efficacy was 59.7%. None of the polymorphisms was linked with the risk of AF recurrence after 6 months in univariate analysis. In multivariate analysis rs2200733 in the recessive model was linked significantly with AF recurrence (odds ratio 1.87, p = 0.008). None of the polymorphisms predicted AF recurrence in long-term follow-up. CONCLUSIONS: There is a trend in the relationship between TT genotype of the rs2200733 polymorphism and increased rate of AF recurrence after PVI in short-term (6 months) follow-up. None of the tested SNPs 4q25, 16q22, and 1q21 correlated with the results of a single AF ablation in long-term follow-up. Termedia Publishing House 2016-02-02 2016-02-01 /pmc/articles/PMC4754358/ /pubmed/26925117 http://dx.doi.org/10.5114/aoms.2015.48284 Text en Copyright © 2016 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Clinical Research Kiliszek, Marek Kozluk, Edward Franaszczyk, Maria Lodzinski, Piotr Piatkowska, Agnieszka Ploski, Rafal Opolski, Grzegorz The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation |
title | The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation |
title_full | The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation |
title_fullStr | The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation |
title_full_unstemmed | The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation |
title_short | The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation |
title_sort | 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754358/ https://www.ncbi.nlm.nih.gov/pubmed/26925117 http://dx.doi.org/10.5114/aoms.2015.48284 |
work_keys_str_mv | AT kiliszekmarek the4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT kozlukedward the4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT franaszczykmaria the4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT lodzinskipiotr the4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT piatkowskaagnieszka the4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT ploskirafal the4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT opolskigrzegorz the4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT kiliszekmarek 4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT kozlukedward 4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT franaszczykmaria 4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT lodzinskipiotr 4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT piatkowskaagnieszka 4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT ploskirafal 4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation AT opolskigrzegorz 4q251q21and16q22polymorphismsandrecurrenceofatrialfibrillationafterpulmonaryveinisolation |